HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Improved myocardial performance induced by clofibrate during reperfusion after acute myocardial infarction.

Abstract
The increase of cellular fatty acids appears to be one of the causes of the myocardial injury during ischemia and reperfusion. This study was designed to examine whether a hypolipidemic drug such as clofibrate can reduce the myocardial injury during ischemia and reperfusion. Clofibrate was fed to experimental pigs for 9 days. Isolated in situ hearts from both experimental and control pigs were subjected to 60 min of regional ischemia induced by occluding the left anterior descending coronary artery, followed by 60 min of global ischemia by hypothermic cardioplegic arrest and 60 min of reperfusion. The clofibrate feeding resulted in the better cardiac performance as judged by increased coronary blood flow, improved left ventricular function, and reduced myocardial injury as judged by creatine kinase release. Although the clofibrate-fed animals contained higher levels of thiobarbituric reactive materials, the free fatty acid levels of plasma and myocardium were much lower compared with control animals. The clofibrate feeding was also associated with increased peroxisomal catalase and beta-oxidation of fatty acids. These results suggest that decreased levels of free fatty acids in the plasma and the myocardium and increased catalase activity induced by antilipolytic therapy appear to provide beneficial effects to the myocardium during ischemia and reperfusion.
AuthorsM R Prasad, R Clement, H Otani, R Jones, D K Das, R M Engelman, R H Breyer, J A Rousou
JournalCanadian journal of physiology and pharmacology (Can J Physiol Pharmacol) Vol. 66 Issue 12 Pg. 1518-23 (Dec 1988) ISSN: 0008-4212 [Print] Canada
PMID3228787 (Publication Type: Journal Article)
Chemical References
  • Fatty Acids
  • Fatty Acids, Nonesterified
  • Lipids
  • Malondialdehyde
  • Catalase
  • Creatine Kinase
  • Clofibrate
Topics
  • Animals
  • Catalase (analysis)
  • Clofibrate (therapeutic use)
  • Coronary Circulation
  • Creatine Kinase (metabolism)
  • Fatty Acids (metabolism)
  • Fatty Acids, Nonesterified (metabolism)
  • Lipids (isolation & purification)
  • Malondialdehyde (analysis)
  • Microbodies
  • Myocardial Contraction (drug effects)
  • Myocardial Infarction (drug therapy)
  • Oxidation-Reduction
  • Reperfusion
  • Swine

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: